Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 18
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 2 |
| Route | NDCs |
|---|---|
| oral | 2 |
| Labeller name on the listing | NDCs |
|---|---|
| crinetics pharmaceuticals, inc. | 2 |
Exclusivity
Patents and exclusivities
18| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10351547 | PALSONIFYpaltusotine hydrochloride | substance, product | Jul 2037 |
| 10597377 | PALSONIFYpaltusotine hydrochloride | substance, product | Jul 2037 |
| 10875839 | PALSONIFYpaltusotine hydrochloride | use | Jul 2037 |
| 11414397 | PALSONIFYpaltusotine hydrochloride | substance, product | Jul 2037 |
| 9896432 | PALSONIFYpaltusotine hydrochloride | substance, product | Jul 2037 |
| 10464918 | PALSONIFYpaltusotine hydrochloride | substance | Jan 2039 |
| 11266641 | PALSONIFYpaltusotine hydrochloride | product | Sept 2041 |
| 11957674 | PALSONIFYpaltusotine hydrochloride | use | Sept 2041 |
| 12208092 | PALSONIFYpaltusotine hydrochloride | use | Mar 2044 |
| Product | Exclusivity | Until |
|---|---|---|
| PALSONIFYPALTUSOTINE HYDROCHLORIDE | ODE-537 Orphan drug | Sept 2032 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| PALSONIFY | PALTUSOTINE | tablet, film coated, oral | 84015-920NDA |
| PALSONIFY | PALTUSOTINE | tablet, film coated, oral | 84015-930NDA |
Enquiry
Common questions
- Is Crinetics Pharmaceuticals, Inc. FDA approved?
- Crinetics Pharmaceuticals, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Crinetics Pharmaceuticals, Inc. make?
- 2 products are listed under Crinetics Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.